Back

Morphological alterations of the cardiomyocyte nuclear envelope may preclude the potential for reverse remodelling in patients with non-ischemic cardiomyopathy.

29 April 2017 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Biomarkers Prognosis (using biomarkers) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Themistoklis Katsimichas

Ippokrateio General Hospital of Athens, Athens (Greece)

24 More presentations in this session

Presentation thumbnail
Doctor M. Cabiati (Pisa, IT)
Presentation thumbnail
Professor C. Meune (Bobigny, FR)
Abstract
Presentation thumbnail
Assistant Professor M. Gegenava (Tbilisi, GE)
Presentation thumbnail
Professor G. Savarese (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Doctor C. Caselli (Pisa, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Biomarkers

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Microtubule-induced restriction of nuclear deformability in hypertrophic cardiomyopathy
13 April 2024
thumbnail
Congress Presentation
Non-ischemic etiology is a better prognostic factor of reverse left ventricular remodeling in patients with heart failure reduced ejection fraction
11 December 2024
thumbnail
Congress Presentation
Nuclear receptor PPAR alpha, transcriptional coactivator PGC-1 alpha and cardiac metabolic remodeling in heart failure
29 June 2021
thumbnail
Congress Presentation
LMNA and left-sided arrhythmogenic cardiomyopathy
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources